Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Papillomavirus Vaccines
Lauri E. Markowitz, John T. Schiller
The Journal of Infectious Diseases (2021) Vol. 224, Iss. Supplement_4, pp. S367-S378
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Contributions of humoral and cellular immunity to vaccine-induced protection in humans
Ian J. Amanna, Mark K. Slifka
Virology (2011) Vol. 411, Iss. 2, pp. 206-215
Open Access | Times Cited: 239
Updates on cervical cancer prevention
David Viveros‐Carreño, Andreína Fernándes, René Pareja
International Journal of Gynecological Cancer (2023) Vol. 33, Iss. 3, pp. 394-402
Closed Access | Times Cited: 52
Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review
Mallory K. Ellingson, Hassan Sheikha, Kate Nyhan, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 43
Vaccines: the Fourth Century
Stanley A. Plotkin
Clinical and Vaccine Immunology (2009) Vol. 16, Iss. 12, pp. 1709-1719
Open Access | Times Cited: 241
Immune markers and correlates of protection for vaccine induced immune responses
Aneesh Thakur, Lasse Eggers Pedersen, Gregers Jungersen
Vaccine (2012) Vol. 30, Iss. 33, pp. 4907-4920
Closed Access | Times Cited: 145
HPV Vaccination: An Underused Strategy for the Prevention of Cancer
Gilla K. Shapiro
Current Oncology (2022) Vol. 29, Iss. 5, pp. 3780-3792
Open Access | Times Cited: 63
Prophylactic Human Papillomavirus Vaccination: From the Origin to the Current State
Ayazhan Akhatova, Azliyati Azizan, Kuralay Atageldiyeva, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1912-1912
Open Access | Times Cited: 46
Human Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap?
Giovanna Milano, Giovanni Guarducci, Nicola Nante, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1060-1060
Open Access | Times Cited: 30
HPV Infections—Classification, Pathogenesis, and Potential New Therapies
Beata Mlynarczyk-Bonikowska, Lidia Rudnicka
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7616-7616
Open Access | Times Cited: 14
The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)
Fatemeh Movahed, Satinik Darzi, Parya Mahdavi, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Prevalence and genotype distribution of HPV infections among women in Chengdu,China
Junying Zhang, Tianzhi Zha, Xuemei Wang, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Socioeconomic and Health-Related Characteristics Associated with Initiation and Completion of Human Papillomavirus Vaccination among Males in the United States: An In-Depth Systematic Review and Meta-Analysis
George N. Okoli, Alexandra Soós, Katharine Etsell, et al.
Behavioral Medicine (2025), pp. 1-22
Closed Access | Times Cited: 1
In the activation of HPV-specific human B cells HPV-VLP vaccines mimic membrane-associated antigens
Charles Torgbor, Haewon Sohn, Brian Dizon, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 10
Open Access | Times Cited: 1
Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases
Perry Barrett, Sara J. Terpening, Doris M. Snow, et al.
Expert Review of Vaccines (2017) Vol. 16, Iss. 9, pp. 883-894
Closed Access | Times Cited: 71
Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies
Catherine Fauvelle, Che C. Colpitts, Zhen–Yong Keck, et al.
Expert Review of Vaccines (2016) Vol. 15, Iss. 12, pp. 1535-1544
Open Access | Times Cited: 62
The status and challenges of HPV vaccine programme in China: an exploration of the related policy obstacles
Huizi Wang, Yujin Jiang, Qing Wang, et al.
BMJ Global Health (2023) Vol. 8, Iss. 8, pp. e012554-e012554
Open Access | Times Cited: 17
Bacteria extracellular vesicle as nanopharmaceuticals for versatile biomedical potential
Ming Yao Ho, Songhan Liu, Bengang Xing
Nano Convergence (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 7
Multiple pathogens and prostate cancer
James S. Lawson, Wendy K. Glenn
Infectious Agents and Cancer (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 25
No woman left behind: achieving cervical cancer elimination among women living with HIV
Kirthana Sharma, Dorothy A. Machalek, Zheng Quan Toh, et al.
The Lancet HIV (2023) Vol. 10, Iss. 6, pp. e412-e420
Closed Access | Times Cited: 13
Treatment of Pediatric Anogenital Warts in the Era of HPV-Vaccine: A Literature Review
Astrid Herzum, Giulia Ciccarese, C. Occella, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4230-4230
Open Access | Times Cited: 13
Enterovirus virus-like-particle and inactivated poliovirus vaccines do not elicit substantive cross-reactive antibody responses
Daniel L. Moss, Alden C. Paine, Peter W. Krug, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 4, pp. e1012159-e1012159
Open Access | Times Cited: 5
Cervical Cancer
Vikrant V. Sahasrabuddhe
Hematology/Oncology Clinics of North America (2024) Vol. 38, Iss. 4, pp. 771-781
Closed Access | Times Cited: 5
Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy
Hongli Wang, Zhi‐Gang Wang, Shu‐Lin Liu
Molecules (2022) Vol. 27, Iss. 17, pp. 5607-5607
Open Access | Times Cited: 22
Trends in Adolescent Human Papillomavirus Vaccination and Parental Hesitancy in the United States
Jodie L. White, M. Kate Grabowski, Anne F. Rositch, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 5, pp. 615-626
Open Access | Times Cited: 12
Berries vs. Disease: Revenge of the Phytochemicals
Felipe Lamenza, Puja Upadhaya, Peyton Roth, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 84-84
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top